Menu Search
Equities

Microport Scientific Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
MSK:FRA

Microport Scientific Corp

Actions
  • Price (EUR)1.19
  • Today's Change0.00 / 0.00%
  • Shares traded684.00
  • 1 Year change+33.71%
  • Beta1.3569
Data delayed at least 15 minutes, as of Feb 16 2026 07:10 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Microport Scientific Corp Microport Scientific Corp is an investment holding company mainly engaged in the sale, manufacture, research and development (R&D) of medical devices. The Company operates in eight segments. The Cardiovascular Devices Business segment includes implantable devices and access devices. The Orthopedics Devices Business segment includes reconstructive joints and spine products. The Cardiac Rhythm Management (CRM) Business segment includes pacemakers and defibrillators. The Endovascular and Peripheral Vascular Devices Business segment includes L-REBOA aortic occlusion balloons. The Neurovascular Devices Business segment includes cerebral atherosclerotic stenosis and coil products. The Structural Heart Disease Business segment includes Transcatheter Aortic Valve Implantation. The Surgical Robot Business segment includes the manufacture and R&D of surgical robot devices. The Surgical Devices Business segment includes the manufacture and R&D of surgical devices.

  • Revenue in HKD (TTM)7.97bn
  • Net income in HKD-1.28bn
  • Incorporated2006
  • Employees6.29k
  • Location
    Microport Scientific CorpNo. 1601 Zhangdong RoadZhangjiang Hi-Tech ParkSHANGHAI 201203ChinaCHN
  • Phone+86 2 138954600
  • Websitehttps://www.microport.com.cn/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.